Results 271 to 280 of about 18,233 (306)

Thromboembolism with low profile bioprosthesis

European Heart Journal, 1984
Low profile bioprosthesis late follow-up indicates a low incidence of thromboembolism. For the entire series of 415 consecutively operated patients (rigid and flexible stents) the actuarial probability of freedom at 6 years is 90.3% (87.8% for MVR and 92.27% for AVR and 95.24% for MVR + AVR).
C. Gimenez, I. Meletti, J. A. Navia, Domingo Liotta   +3 more
openaire   +3 more sources

Balloon valvoplasty of mitral bioprosthesis

International Journal of Cardiology, 1991
We describe a case of percutaneous balloon valvoplasty of a stenotic Ionescu-Shiley mitral bioprosthesis with the help of an original emboli-protecting device. The procedure reduced diastolic gradient from 29 to 9 mmHg. The calculated area of the orifice increased from 0.7 to 1.7 cm2.
Uros U. Babic, Mihajlo Vucinic, Sreten Grujicic   +2 more
openaire   +3 more sources

Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years.

EuroIntervention, 2019
AIMS The aim of this study was to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation (TAVI) with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve ...
R. Panico, C. Giannini, M. De Carlo, M. Angelillis, P. Spontoni, A. Pieroni, G. Costa, P. Bertini, F. Guarracino, A. Petronio   +9 more
semanticscholar   +1 more source

Pregnancy in patients with a porcine valve bioprosthesis

The American Journal of Cardiology, 1982
Seven patients who became pregnant after valve replacement with a Hancock bioprosthesis were followed up during 8 pregnancies. Six had undergone isolated mitral valve replacement, and 1 had mitral and aortic valve replacement. Their age at the time of operation ranged from 14 to 31 years (average 24); delivery occurred 21 to 88 months (average 51.3 ...
BORTOLOTTI U, MILANO A, MAZZUCCO A, VALFRE C, RUSSO R, VALENTE, MARIALUISA, SCHIVAZAPPA, L, THIENE, GAETANO, GALLUCCI V. AM J. C.A.R.D.I.O.L. NOV   +8 more
openaire   +5 more sources

The Hancock II bioprosthesis at ten years

The Annals of Thoracic Surgery, 1995
The Hancock II bioprosthesis was used for heart valve replacement in 843 patients from 1982 to 1993. Aortic valve replacement (AVR) was performed in 536 patients, mitral valve replacement (MVR) in 250, and aortic and mitral valve replacement (DVR) in 57. The mean age was 64 +/- 12 years.
Susan J. Armstrong, Zhao Sun, Tirone E. David   +2 more
openaire   +5 more sources

A rare case of aortic bioprosthesis thrombosis

Acta Cardiologica, 2010
Chronic thrombosis of the Carpentier-Edwards SAV porcine aortic bioprosthesis is a very rare complication.We present the case of an 80-year-old male patient with dyspnoea NYHA class III 30 months after coronary artery bypass grafting and aortic valve replacement.
Ruben Hamerlijnck, Johan De Sutter, Philippe Selleslagh   +2 more
openaire   +3 more sources

Repeat replacement of aortic valve bioprosthesis

The Annals of Thoracic Surgery, 1995
We describe a safe and simple technique for replacing an aortic valve bioprosthesis in a patient who also had a previously implanted ascending aortic graft and multiple coronary artery bypass grafts. This method allows for isolated valve replacement without removal of the ascending aortic graft or alteration of the coronary artery bypass graft ...
Dimitrios C. Iliopoulos, Hazim J. Safi, Diana S. Duff   +2 more
openaire   +3 more sources

Repositionable self-expanding aortic bioprosthesis

Expert Review of Medical Devices, 2017
Transcatheter aortic valve implantation/replacement (TAVI or TAVR) has been established as a first line therapy in patients with symptomatic severe aortic stenosis (AS) at high or prohibitive surgical risk and as an alternative in elderly patients with intermediate surgical risk.
Bruna Gomes, Hugo A. Katus, Raffi Bekeredjian   +2 more
openaire   +3 more sources

The New Labcor-Santiago Pericardial Bioprosthesis

Journal of Cardiac Surgery, 1991
The Labcor-Santiago pericardial valve has been designed to minimize mechanical stress and to avoid abrasion wear, at the same time preserving the concept of mounting the pericardium outside the posts for full orifice opening. The new design has preserved the traditional superior hemodynamic performance of pericardial valves, avoiding abrasion by ...
José Ramón González-Juanatey, Luis Puig, Juan Sierra, Darío Durán, José A. Rubio, Jose B. Garcia-Bengochea, Ivan Casagrande   +6 more
openaire   +3 more sources

The INTACT Bioprosthesis - Early Results

Journal of Cardiac Surgery, 1988
The INTACT (previously Xenotech) valve incorporates three major departures from previously available bioprostheses. The following innovations are aimed at reducing calcification and improving durability: (1) the stent has a high profile configuration and the sinuses are deeply excavated.
openaire   +3 more sources